Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
about
Updated overview of current biomarkers in head and neck carcinomaMultifocal epithelial tumors and field cancerization: stroma as a primary determinantTelomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical MarginsA gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence.Molecular biology of squamous cell carcinoma of the head and neckHistological and molecular aspects of oral squamous cell carcinoma (Review)Clinicopathologic significance and survival of TIP30 expression in laryngeal squamous cell carcinomaAssociation of OPN overexpression with tumor stage, differentiation, metastasis and tumor progression in human laryngeal squamous cell carcinoma.Tissue imprint for molecular mapping of deep surgical margins in patients with head and neck squamous cell carcinomaFlower-deficient mice have reduced susceptibility to skin papilloma formationThe utility of molecular diagnostics to predict recurrence of head and neck carcinoma.Mitochondria as a target for early detection and diagnosis of cancer.The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissuesMolecular profiling of laryngeal cancer.Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.Molecular findings in oral premalignant fields: update on their diagnostic and clinical implications.Immunotherapy for head and neck cancer patients: shifting the balance.The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications.Oral field cancerization: an update on current concepts.Open questions and novel concepts in oral cancer surgery.Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges.Molecular Patterns and Biology of HPV-Associated HNSCC.Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach.Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy.Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.Asymmetrical proliferative pattern loss during malignant transformation of the oral mucosa.Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.HPV-Induced Field Cancerisation: Transformation of Adult Tissue Stem Cell Into Cancer Stem Cell.MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.
P2860
Q26750659-7D9728CF-1FD0-4767-8CDA-9683C412D7BCQ27005678-66D115FF-2D9F-413B-A228-0985761DC0BBQ30248577-B5861838-F81C-4EFC-9E51-9460B84EC3C4Q33741519-20539918-56F0-4913-95EC-7BB877E14E6DQ34046527-CA80F453-8A6F-4158-9976-5E58E7291F7CQ34518716-12EF0302-94E3-4907-B8EA-A0B0E01ED695Q34662689-6FA24629-A119-4E37-98F3-E80B865983A2Q35792189-2F2DC6A8-215A-4D27-80C8-04EDFB74D234Q35870683-F8878DD9-A730-434D-853E-FF38332525D4Q36038504-998CB583-41C4-44C5-BB34-ED310B38DAE3Q36051086-82A174BC-AB2A-4EE2-92F5-F7910FB56FBAQ36287929-63C1A099-2ACA-49E8-8C78-247470309CA7Q36359505-55858451-3B5A-4129-BE98-A56F42CFA35DQ37287554-BFF7D4C1-7654-46D1-BF4A-C38FB149606FQ37598935-252CED0B-1A25-4727-B863-38BB93072A3CQ37641638-91916B79-1BFA-4DED-A123-371580045304Q37919575-FE9C5BD3-9396-4428-B32B-90D86A5A0867Q38068966-740EAEC4-0ADF-440D-94A5-495EB613EA70Q38079588-40E0EE48-0ADC-46C8-8D67-5096DDAF53FAQ38087239-651A25EE-A034-4370-9BCB-1B2A1A7C2C1BQ38493190-8376FF98-A385-4636-994D-4226A2EE4E06Q38499825-54504AAA-8715-4CDA-AAD4-557DFB5A5218Q38653658-E4CED586-31EC-41DA-BC51-4DA0145A879FQ38836747-D487D3C9-4236-4EF6-BF54-A55E9A25F11AQ38971530-69441544-C4D6-4E0C-A55D-B7176300D11FQ39134863-C6980D78-0D5E-4DB8-AD52-7989A1EA02D8Q39603028-124ACE3B-2E97-4D6D-830F-CB5D5FD46CA8Q39861412-0AA0A5BD-5DC8-4587-815B-5F9C77F8D668Q42254654-B1C23F48-CBC6-4F92-94A8-D68613EAE015Q42464973-86C3132F-4543-412D-A90A-CF98307DAE7BQ43412784-6CAE40D7-41F1-4797-B188-FA4305389158Q47230963-03654520-9A09-4DAA-BCC3-F1E1035913C5Q51814676-D24200B0-92AD-4796-B156-9305C22636E3Q52597650-9889E843-74FD-428A-8FA7-8300BAC9B319Q53226065-AB8A672D-1D2C-4935-B0EC-39FC21929664Q54327684-BBC27194-15A9-4C9B-91FA-1BC07EE0462E
P2860
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
@en
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
@nl
type
label
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
@en
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
@nl
prefLabel
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
@en
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
@nl
P2093
P356
P1476
Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
@en
P2093
Fedor Denkers
Gordon B Snow
Isaäc van der Waal
J Alain Kummer
Janny Dijkstra
Maarten P Tabor
Michiel W M van den Brekel
René Leemans
Ruud H Brakenhoff
Viola M M van Houten
P304
P356
10.1002/PATH.1242
P577
2002-12-01T00:00:00Z